| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.089 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |